According to the Human Protein Atlas, the predicted target genes PLCG1 (https://www.proteinatlas.org/ENSG00000124181-PLCG1/pathology) and TRIM25 (https://www.proteinatlas.org/ENSG00000121060-TRIM25/pathology) are of high relevance in pancreatic cancer, because patients with high PLCG1 (n = 110) or TRIM25 (n = 121) expression survive longer than those with low expression (n = 66, N = 55, respectively). The gene discussed is TRIM25; the disease is pancreatic neoplasm.